Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
-
Blue Rhino Renews its Partnership with the Steak Cookoff Association
-
Sprott Launches Copper Miners ETF
-
Aktia Bank Plc: Managers’ Transactions – Anssi Huhta
-
Aktia Bank Plc: Managers’ Transactions – Outi Henriksson
-
Aktia Bank Plc: Managers’ Transactions – Juha Hammarén
-
BEZTAK AWARDED 44 KINGSLEY EXCELLENCE AWARDS, WITH ALL SEASONS BIRMINGHAM IN #1 PLACEMENT
-
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
-
TRxADE Health, Inc. Announces Special Cash Dividend
-
Unlimited Builds Out C-Suite, Appointing Hedge Fund Veteran John K. E. Morris as Chief Commercial Officer
-
Dimensional Fund Advisors Ltd. : Form 8.3 - WINCANTON PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Urban Logistics REIT plc - Ordinary Shares
-
Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapies Designed to Address Immune Dysfunction
-
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
-
Odyssey Trust Company Announces Collaboration with Generation IACP Inc.
-
Krispy Kreme® Canada expands with the opening of its first Winnipeg location
-
Infinidat Is Recognized in the 2024 Gartner® Peer Insights™ Voice of the Customer for Primary Storage as North America Customers’ Choice for the Second Consecutive Year
-
Asia Broadband Signs Definitive Acquisition Agreement for High-Grade Gold Property in Jalisco Mexico
-
Bearing AI Launches EU ETS Compliance Tool
-
Araris Biotech AG to Present Data on Antibody-Drug Conjugate Candidates at American Association for Cancer Research (AACR) Annual Meeting 2024
-
Werewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma Conference
-
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit
-
INNOVATE Corp. Announces Rights Offering Pricing
-
BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UK COMMERCIAL PROPERTY REIT - Ordinary Shares
-
Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia
-
Par Pacific Management to Participate in Investor Conferences
-
REE Announces Closing of Public Offering of Ordinary Shares
-
Infinera Announces Availability of Next Generation Multi-haul Optical Line System Functionality for Industry-leading GX Series Platform
-
CPS Technologies and Triton Systems Announce New Licensing Agreement
-
Apnimed to Participate in the Upcoming Leerink Partners Global Biopharma Conference
-
Greenridge Exploration Engages Dahrouge Consulting
-
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
-
Auron Announces Poster Presentations at 2024 AACR Annual Meeting
-
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
-
Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director
-
M&C Communications marks its 15th anniversary with the addition of two new team members
-
Cidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association dor Cancer Research (AACR) Annual Meeting 2024
-
Gabelli Funds to Host 15th Annual Specialty Chemicals Symposium Thursday, March 14, 2024
-
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers
-
Kiosks are #1 Priority in 2024 for QSR and Fast Casual Restaurants According to Survey that Reveals New Trends in Digital Channels, Self-service Options, Loyalty Frameworks, and AI
-
Replimune to Present at the American Association for Cancer Research Annual Meeting 2024
-
Syncromune® Inc. to Present Initial Clinical Data from SYNC-T™ SV-102 Phase 1 as a Late-Breaker at the American Association for Cancer Research Annual Meeting 2024
-
Avalyn to Participate in Leerink Partners Global Biopharma Conference
-
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
-
Frontier Medicines to Present Preclinical Data at the American Association for Cancer Research Annual Meeting 2024
-
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
-
Noah Medical Named a “Fierce 15” Company of 2023 by Fierce MedTech
-
Fobi AI to Provide Digital Ticketing for the 36th Annual ROTH Conference on March 17-19, 2024, in Dana Point, CA
-
Ubiquitech Software Corp. (OTC:UBQU) Announces Strategic Acquisition of Innovative Outcomes, Inc., an Established Leader in the Multi-Billion Dollar Medical Wound Care Segment
